Seroprevalence of anti–SARS-CoV-2 IgG antibodies in Kenyan blood donors-Reference-Cited by-同舟云学术

Seroprevalence of anti–SARS-CoV-2 IgG antibodies in Kenyan blood donors

Published:2021-01 Issue:6524 Volume:371 Page:79-82
ISSN:0036-8075
Container-title:Science
language:en
Short-container-title:Science

Author:

Uyoga Sophie¹^ORCID,Adetifa Ifedayo M. O.¹²^ORCID,Karanja Henry K.¹^ORCID,Nyagwange James¹^ORCID,Tuju James¹^ORCID,Wanjiku Perpetual¹^ORCID,Aman Rashid³,Mwangangi Mercy³,Amoth Patrick³,Kasera Kadondi³^ORCID,Ng’ang’a Wangari⁴^ORCID,Rombo Charles⁵,Yegon Christine⁵,Kithi Khamisi⁵,Odhiambo Elizabeth⁵,Rotich Thomas⁵^ORCID,Orgut Irene⁵,Kihara Sammy⁵,Otiende Mark¹^ORCID,Bottomley Christian²,Mupe Zonia N.¹^ORCID,Kagucia Eunice W.¹^ORCID,Gallagher Katherine E.¹²^ORCID,Etyang Anthony¹^ORCID,Voller Shirine¹²,Gitonga John N.¹,Mugo Daisy¹^ORCID,Agoti Charles N.¹,Otieno Edward¹^ORCID,Ndwiga Leonard¹^ORCID,Lambe Teresa⁶^ORCID,Wright Daniel⁶^ORCID,Barasa Edwine¹,Tsofa Benjamin¹^ORCID,Bejon Philip¹⁶,Ochola-Oyier Lynette I.¹,Agweyu Ambrose¹^ORCID,Scott J. Anthony G.¹²,Warimwe George M.¹⁶^ORCID

Affiliation:

1. KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya.

2. Department of Infectious Diseases Epidemiology, London School of Hygiene and Tropical Medicine, Keppel Street, London, UK.

3. Ministry of Health, Government of Kenya, Nairobi, Kenya.

4. Presidential Policy and Strategy Unit, The Presidency, Government of Kenya, Nairobi, Kenya.

5. Kenya National Blood Transfusion Services, Ministry of Health, Nairobi, Kenya.

6. Nuffield Department of Medicine, Oxford University, Oxford, UK.

Abstract

Pandemic progress in Kenya By the end of July 2020, Kenya had reported only 341 deaths and ∼20,000 cases of COVID-19. This is in marked contrast to the tens of thousands of deaths reported in many higher-income countries. The true extent of COVID-19 in the community was unknown and likely to be higher than reports indicated. Uyoga et al. found an overall seroprevalence among blood donors of 4.3%, peaking in 35- to 44-year-old individuals (see the Perspective by Maeda and Nkengasong). The low mortality can be partly explained by the steep demographics in Kenya, where less than 4% of the population is 65 or older. These circumstances combine to result in Kenyan hospitals not currently being overwhelmed by patients with respiratory distress. However, the imposition of a strict lockdown in this country has shifted the disease burden to maternal and child deaths as a result of disruption to essential medical services. Science , this issue p. 79 ; see also p. 27

Funder

Oak Foundation

Wellcome

Medical Research Council

African Academy of Sciences

DFID and Wellcome

NIHR MPRU

Department for International Development

NIHR Health Protection Research Unit in Immunisation

Publisher

American Association for the Advancement of Science (AAAS)

Subject

Multidisciplinary

Reference32 articles.

1. United Nations Department of Economic and Social Affairs Population Division “World Urbanization Prospects: The 2018 Revision ” custom data acquired via (2018); https://population.un.org/wup/DataQuery.

2. Africa Centres for Diseases Control and Prevention “Coronavirus Disease 2019 (COVID-19)” (2020); https://africacdc.org/covid-19[accessed 21 July 2020].

3. The relatively young and rural population may limit the spread and severity of COVID-19 in Africa: a modelling study

4. Demographic science aids in understanding the spread and fatality rates of COVID-19

5. Ministry of Health Kenya “Press Statement on the update of the coronavirus in the country and response measures” (2020); www.health.go.ke/wp-content/uploads/2020/03/Coronavirus-Press-Statement-March-17-2020.pdf.

Cited by 240 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparative reconstruction of SARS-CoV-2 transmission in three African countries using a mathematical model integrating immunity data;IJID Regions;2024-03

2. Modeling the health impact of increasing vaccine coverage and nonpharmaceutical interventions against coronavirus disease 2019 in Ghana;Pathogens and Global Health;2024-02-06

3. Analysis of SARS-CoV-2 antibody seroprevalence in Northern Ireland during 2020–2021;Heliyon;2024-01

4. The evolution and interpretation of seroprevalence of SARS‐CoV‐2 antibodies among South African blood donors from the Beta to Omicron variant‐driven waves;Vox Sanguinis;2023-12-29

5. Seroprevalence of Anti-SARS-CoV-2 Remained Extremely Low in Taiwan Until the Vaccination Program Was Implemented;Open Forum Infectious Diseases;2023-12-14